Clenziderm M.d. System Kit
NDC Package 62032-613-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Clenziderm M.d. System (salicylic acid and benzoyl peroxide) kits is cleanse the entire affected area with a thin layer and rinse thoroughly one to three times daily.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day. This formulation utilizes a kit delivery system. Marketed by Obagi Cosmeceuticals Llc, this product is identified by NDC 62032-613 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
62032-613-01
Package Description
1 KIT in 1 CARTON * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)
Product Code
62032-613
11-Digit Billing Format
62032061301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Clenziderm M.d. System Acne Therapeutic System
Non-Proprietary Name
Salicylic Acid And Benzoyl Peroxide
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Cleanse the entire affected area with a thin layer and rinse thoroughly one to three times daily.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day. Cleanse the skin thoroughly before applying this product.Shake product well before use.Place a cotton ball or pad over the pump well and pump 2 to 3 times to saturate, then cover the entire affected area with a thin layer one to three times daily.Allow the product to air-dry completely; do not rinse off.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day . Cleanse the skin thoroughly before applying this product.Cover the entire affected area with a thin layer one to three times daily.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day.If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.

Regulatory & Marketing

Labeler Name
Obagi Cosmeceuticals Llc
Product Type
Human Otc Drug
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (62032-613). Click a package code to view its specific billing and regulatory data.

62032-613-09
1 KIT in 1 CARTON * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)
62032-613-15
1 BAG in 1 CARTON / 1 KIT in 1 BAG * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 47 mL in 1 BOTTLE, PLASTIC (62032-611-01) * 118 mL in 1 BOTTLE, PLASTIC (62032-610-11)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62032-613-01 identifies a specific commercial package of 1 kit in 1 carton * 148 ml in 1 bottle, plastic (62032-612-04) * 47 ml in 1 bottle, plastic (62032-611-01) * 118 ml in 1 bottle, plastic (62032-610-11) of Clenziderm M.d. System Acne Therapeutic System, a human over the counter drug labeled by Obagi Cosmeceuticals Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Obagi Cosmeceuticals Llc on January 01, 2012. The current certification is valid through December 31, 2026.

How is this Obagi Cosmeceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62032061301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62032-613-01
11-Digit CMS (5-4-2)
62032-0613-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.